Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Acute megakaryoblastic leukemia with acquired trisomy 21 and GATA1 mutations in phenotypically normal children.

Authors:
Rintaro Ono Daisuke Hasegawa Shinsuke Hirabayashi Takahiro Kamiya Kenichi Yoshida Satoko Yonekawa Chitose Ogawa Ryota Hosoya Tsutomu Toki Kiminori Terui Etsuro Ito Atsushi Manabe

Eur J Pediatr 2015 Apr 30;174(4):525-31. Epub 2014 Sep 30.

Department of Pediatrics, St. Luke's International Hospital, 9-1, Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan,

Unlabelled: GATA1 mutations are found almost exclusively in children with myeloid proliferations related to Down syndrome (DS). Here, we report two phenotypically and cytogenetically normal children with acute megakaryoblastic leukemia (AMKL) whose blasts had both acquired trisomy 21 and GATA1 mutation. Patient 1 was diagnosed with transient abnormal myelopoiesis in the neonatal period. Following spontaneous improvement of the disease, leukemic blasts increased 7 months later. He received less intensive chemotherapy, and he is now 6 years old in complete remission. Patient 2 was diagnosed with AMKL at the age of 18 months. Although he received intensive chemotherapy and a cord blood transplantation, he died without gaining remission. In both cases, trisomy 21 and GATA1 mutation were detected only in leukemic blasts, but not in germline samples. Based on a literature review, we identified reports describing 14 non-DS AMKL with GATA1 mutation and acquired trisomy 21. Of those, 12 cases were diagnosed during the neonatal period, whereas the remaining 2 cases were diagnosed at the age of 22 and 31 months, respectively.

Conclusion: These cases suggest that GATA1 mutation may cooperate with the additional chromosome 21 in developing myeloid proliferations even in non-DS patients.

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00431-014-2430-3DOI Listing
April 2015

Publication Analysis

Top Keywords

gata1 mutation
16
acquired trisomy
12
trisomy gata1
12
intensive chemotherapy
8
normal children
8
received intensive
8
acute megakaryoblastic
8
neonatal period
8
patient diagnosed
8
myeloid proliferations
8
cases diagnosed
8
leukemic blasts
8
gata1 mutations
8
megakaryoblastic leukemia
8
gata1
6
mutation cooperate
4
gaining remission
4
died gaining
4
additional chromosome
4
transplantation died
4

Keyword Occurance

Similar Publications

Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs.

Authors:
Filomena Longo Andrea Piolatto Giovanni Battista Ferrero Antonio Piga

Int J Mol Sci 2021 Jul 5;22(13). Epub 2021 Jul 5.

Department of Clinical and Biological Sciences, University of Torino, 10043 Torino, Italy.

β-thalassaemia is a rare genetic condition caused by mutations in the β-globin gene that result in severe iron-loading anaemia, maintained by a detrimental state of ineffective erythropoiesis (IE). The role of multiple mechanisms involved in the pathophysiology of the disease has been recently unravelled. The unbalanced production of α-globin is a major source of oxidative stress and membrane damage in red blood cells (RBC). Read More

View Article and Full-Text PDF
July 2021
Similar Publications

Mapping the cellular origin and early evolution of leukemia in Down syndrome.

Authors:
Elvin Wagenblast Joana Araújo Olga I Gan Sarah K Cutting Alex Murison Gabriela Krivdova Maria Azkanaz Jessica L McLeod Sabrina A Smith Blaise A Gratton Sajid A Marhon Martino Gabra Jessie J F Medeiros Sanaz Manteghi Jian Chen Michelle Chan-Seng-Yue Laura Garcia-Prat Leonardo Salmena Daniel D De Carvalho Sagi Abelson Mohamed Abdelhaleem Karen Chong Maian Roifman Patrick Shannon Jean C Y Wang Johann K Hitzler David Chitayat John E Dick Eric R Lechman

Science 2021 07;373(6551)

Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.

Children with Down syndrome have a 150-fold increased risk of developing myeloid leukemia, but the mechanism of predisposition is unclear. Because Down syndrome leukemogenesis initiates during fetal development, we characterized the cellular and developmental context of preleukemic initiation and leukemic progression using gene editing in human disomic and trisomic fetal hematopoietic cells and xenotransplantation. GATA binding protein 1 () mutations caused transient preleukemia when introduced into trisomy 21 long-term hematopoietic stem cells, where a subset of chromosome 21 microRNAs affected predisposition to preleukemia. Read More

View Article and Full-Text PDF
July 2021
Similar Publications

RNA-regulatory exosome complex confers cellular survival to promote erythropoiesis.

Authors:
Charu Mehta Isabela Fraga de Andrade Daniel R Matson Colin N Dewey Emery H Bresnick

Nucleic Acids Res 2021 Jun 1. Epub 2021 Jun 1.

Department of Cell and Regenerative Biology, Wisconsin Blood Cancer Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.

Cellular differentiation requires vast remodeling of transcriptomes, and therefore machinery mediating remodeling controls differentiation. Relative to transcriptional mechanisms governing differentiation, post-transcriptional processes are less well understood. As an important post-transcriptional determinant of transcriptomes, the RNA exosome complex (EC) mediates processing and/or degradation of select RNAs. Read More

View Article and Full-Text PDF
June 2021
Similar Publications

[Analysis of Clinical Characteristics and Prognosis in Children with Acute Megakaryoblastic Leukemia without Down Syndrome].

Authors:
Shao-Fen Lin Shu-Yi Guo Su Liu Jian Wang Ke Huang Yang Li Jian-Pei Fang Dun-Hua Zhou

Zhongguo Shi Yan Xue Ye Xue Za Zhi 2021 Apr;29(2):374-380

Department of Pediatrics, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, Guangdong Province,

Objective: To analyze the clinical characteristics and treatment effects of children with acute megakaryoblastic leukemia without down syndrome (non-DS-AMKL).

Methods: The clinical data of 19 children with non-DS-AMKL treated in the Pediatric Hematology Ward in Sun Yat-sen Memorial Hospital of Sun Yat-sen University from May 2008 to April 2018 were analyzed retrospectively. The clinical characteristics, laboratory test and treatment methods of the children were concluded. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Acute megakaryoblastic leukemia with a novel GATA1 mutation in a second trimester stillborn fetus with trisomy 21.

Authors:
Arturo Bonometti Gessica Lobascio Emanuela Boveri Stefania Cesari Mauro Lecca Alessia Arossa Arsenio Spinillo Edoardo Errichiello Marco Paulli

Leuk Lymphoma 2021 Mar 30:1-4. Epub 2021 Mar 30.

Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.

View Article and Full-Text PDF
March 2021
Similar Publications